Organ printing technology or robotic additive biofabrication of 3D functional tissue and organ constructs is based on using tissue spheroids as building blocks. In order to bioprint human organs it is necessary to develop technology for scalable production of millions tissue spheroids. Ideally, these tissue spheroids must have standard size and shape suitable for bioprinting process. The scalable biofabrication of large volume of standard size tissue spheroids could be achieved only by maximal employment of robotics and automation technologies. The three main competing groups of emerging tissue spheroid biofabrication technologies include: i) modified handing drop method, 2) molded non-adhesive hydrogel technology and iii) digital microfluidic technologies. The comparative analysis of emerging scalable tissue spheroid biofabrication technologies has been performed. Our data indicates that all these technologies have potential for robotization and automation. The molded non-adhesive hydrogel technologies provide best outcome for standardization of tissue spheroid size. The microfluidics technology has strong advantage in accelerating of tissue spheroids biofabrication (theoretically, up to 10 000 droplets per second). New emerging approaches for biofabrication tissue spheroid using nanopatterned biomimetic surface and technologies for tissue spheroid encapsulation and functionalization will be also presented. The tissue spheroid biofabrication technologies are still evolving and represent hot area in biofabrication research. Moreover, these technologies are already subject of ongoing commercialization. Thus, it is safe to predict that scalable robotic tissue spheroid biofabricators must be integrated parts of organ biofabrication line.
Introduction
Organ printing is a computer-aided robotic layer by layer additive biofabrication using living tissue spheroids as building blocks. [1] [2] [3] [4] The fundamental biophysical principle of organ printing technology is intrinsic capacity of tissue spheroid for tissue fusion driven by surface tension forces. Tissue fusion is an ubiquitous process during the embryonic development. Implementation of organ printing is not possible without development of technology for large scale production of living tissue spheroids. Thus, robotic biofabrication of self-assembling tissue spheroids at large scale is an important technological imperative.
Why tissue spheroids?

Tissue spheroids as building blocks
Tissue spheroids have the small size and ideal geometric form for bioprinting. Tissue spheroids are formed by cell aggregation and have the maximal possible initial cell density. They have an intrinsic capacity for tissue fusion which make them an ideal building material or some sort of living building blocks. They can have complex composition and be prevascularized. Most importantly, as it will shown here tissue spheroids could be produced automatically using robots in large amounts and of uniform size and shape [4] .
How many tissue spheroids are necessary in order to print human organ?
If we assume that the approximate size of average adult human kidney is 100 mm x 50 mm x 50 mm then the estimated volume of such human organ will be 250 000 mm 3 . If we assume that average diameter of tissue spheroid is 0,2 mm or 200 micrometers the in order to bioprinter human organ of kidney size we must biofabricate 6.250.000 (6,25 mln) of tissue spheroids. It have been reported recently that it is possible to robotically biofabricate using non-adhesive molds placed in standard 96 multiwells up to 5000 tissue spheroids per multiwall. Thus, we will need 1.250 multiwells with 5000 tissue spheroid in each in order to bioprint one human organ. It is also conceivable that one middle size dispensing robot can effectively handle approximately up to 50 multiwells. If it will be that case then in order to robotically biofabricate one human organ we will need just 5 dispensing robots which can produce 250 multiwells. This simple calculation demonstrates that even at recent level of technology development the transition from low scale laboratory method of biofabrication to large scale industrial biofabrication of tissue spheroids in desirable volume is technologically feasible. We must not forget that commercially available robotic fluid dispensor and multiwall handling robots are also of the different scale. Robotic fluid dispensor will be able to produce enough tissue spheroid for bioprinting human organ like kidney.
Material properties of tissue spheroids o .
Why it is important to know material properties of tissue spheroids? The material properties of the tissue spheroids are essential to know because of several reasons. Firstly, capacity of tissue spheroids to undergo tissue fusion directly depends on their material properties. The more rigid tissue spheroid fuses more slowly. The level of maturation of tissue spheroids such as chondrospheres and osteospheres is manifested in their material properties and could be used as one of objective criteria of their functional maturation. Materiall propertis of tissue spheroid could be also used for their standardization. Finally, if tissue spheroid is a building block [4] or even is a specific living form of biomaterial [5] and we want to build complex construction like human organ, it is not a bad idea to know what are the material properties of building material.
To measure quantitatively and precisely the material properties of tissue spheroid is not a trivial thing. However, there are already several approaches for study material properties of tissue spheroids which have been developed and successfully implemented (Figure 1) . Historically the compression of living tissue spheroid using parallel plate or tensiometer was one of the first method of quantitative estimation of their material properties [6] . However, it is subject of some criticism now because technology of measurement is based on some unconfirmed assumptions [7] . More recently aspiration assay is becoming increasingly popular for study tissue spheroid [8] . However, measurement by aspiration assay reflects more local material properties rather than desirable global material properties. Another method is based on tissue spheroids spreading [9] . Finally, recently simple and elegant microfluidics method for study tissue spheroid material properties have been developed and experimentally tested [10] . Microfluidics method as well as indirect method based on non-invasive but carefully calibrated impedance measurements could be employed for high throughput screening of tissue maturation factors and also for quality control of tissue spheroid at industrial scale.
Method of scalable robotic biofabrication of tissue spheroids
Modified hanging drop methods.
Handing drop method is a classic biological method which was used by Prof. Aleksander Maximow as some sort of minibioreactor for cell culturing in the beginning of XX century. According our personal experience the main limitation of hanging drop method was low reproducibility due to satellite formation and laborious handling. However, two companies InSphero and 3D Biomatrix recently modified this method by making hanging drop droppable and thus allow applying robotic automated dispensing ( Figure 2) [11,12]. 
Non-adhesive molded hydrogel.
Non-adhesive hydrogel molding has been commercialized by Brown University start-up company [13] . It is also gravity based approach and it is based placing cell suspension into microrecession in non-adhesive agarose hydrogel. We recently modified this method by using more dense mold and robotization approach [14] (Figure 3 ).
Digital microfluidics.
Digital microfluidics based method of scalable biofabrication of tissue spheroids theoretically can produce up to 10 000 spheroids per second. Coaxial droplet generator has been developed and tested [15] . thus, digital microfluidics is one of most perspective method of scalable biofabrication of tissue spheroids. However, the issue of low cell density in hydrogel droplets generated by microfluidics droplet generating devices must be addressed and technology must be optimized (Figure 4 ).
Tissue spheroids biofabricating companies m
One of the best objective indicators of the maturation of any technology is initiation of technology transfer or commercialization of technology. Both modified hanging drop method and non-adhesive hydrogel molding method of tissue spheroid biofabrication have been commercialized. It is safe to predict that microfluidics will be next. There are some tissue spheroids such as chondrospheres and cardiospheres which are already in clinical trial (Table 1) . Fig. 3 . Scalable robotic biofabrication of tissue spheroids using nonadhesive hydrogel molding technology. a) mold ; b) scheme of the method; c) robotic fluid dispenser (EpMotion-5075, Eppendorf, Germany).
Novel emerging methods of tissue spheroids d d biofabrication
The improvement of tissue spheroid biofabrication is ongoing process. Recently, several interesting approaches for biofabrication of tissue spheroids based on creative employment of novel physical and chemical principles have been developed which include using thermo-reversible hydrogel [16], cell surface modification [17] , dielectrophoresis [18] , magnetic levitation [19] , nanopatterned surface like pillared sheet based on biomimetic principle of so- [20] . It clearly reflects the ongoing progress in the development of novel more sophisticated method of tissue spheroid biofabrication. However, from the position of criteria of scalability not all of these sophisticated methods have been proven potentially useful or suitable for clinical translation and not all have strong potential for scaling up. For example, because of single cell level precision and elegant simplicity of dielectropheresis principle deserves special attention. The emerging nanotechnology such as nanopatterned pillared sheet and patterned nanosurface from thermosensitive hydrogel could be also scalable because surface area coated with attachment permissive and thermoreversible hydrogel can control number of attached cells.
From another side, using sophisticated method of cell surface engineering and cell modification with DNA doubly could be clinically relevant method as well as method based on intensive using nanoparticles or other potentially toxic nanomaterials for cell levitation and scalable production of clinically relevant tissue spheroids. 
Post-fabrication processing: functionalization and f f cryopreservation of tissue spheroids
Cryopreservation of tissue spheroids
This issue is still under discussion and there is no clear consensus between researchers -do we need to develop cryopreservation technology for long term storage and transportation of biofabricated tissue spheroids or they must be fabricated only locally (ideally inside hospital or even operation room) and used for organ printing only freshly fabricated. It is a complex biological, technological and also economic question and heavily based on using only autologous or also allogeneic cells, using integrated or separated robotic systems, and selected centralized or decentralized (local) business model. What is important from biological and biotechnological point of view that the efficient cryopreservation technologies with clinically relevant and sufficient level of viability of tissue spheroids after thawing have been already developed.
Harvesting and translocation of tissue spheroids
Tissue spheroids as sobioprinter, which automatically implies that from technological point of view the bioprinter must have either cartridge loaded with bioink like desktop inkjet printers or it must have a direct connections with multiwells or digital microfluidics systems which biofabricate tissue spheroids. In first case scenario we must developed cartridge and probably deal with cryopreserved tissue spheroids. In second case scenario we must develop effective methods of translocation of freshly biofabricated tissue spheroids directly into bioprinter dispensing head or nozzle. More traditional pressurized or gravity based approaches could be and must be initially explored on feasibility. However, possible technological platforms exploring acoustic, electric and magnetic levitation of tissue spheroids as the way of their rapid translocation and dispensing in robotic bioprinter also deserves special attention and systematic exploration on feasibility of such approaches. Only one original paper was specially devoted to issue of harvesting and it have been reported the method of tissue spheroids harvesting based on squeezing hydrogel where microrecession for biofabrication of tissue spheroid have been made. Another advantage of this method that is potentially suitable for highly desirable automation and robotization [21] .
In any case, tissue spheroids translocation from zone of their biofabrication toward bioprinter is not a trivial biological and engineering task and still basically either ignored or just overlooked.
Functionalization of tissue spheroids.
Functionalization of tissue spheroids is directly related to their storage in cartridge and movement or translocation. In order to prevent preliminary and undesirable tissue spheroid fusion in cartridge during bioprinting process they must be encapsulated in highly non-adhesive and lubrificated hydrogel such as hyaluronan which is usually used for coating endovascular device for interventional cardiology. There are several commercial companies producing encapsulators. The commercial encapsulators have been initially designed for immunoisolation of pancreatic islands but they could be also relatively easy adapted for encapsulation of not natural but biofabricated tissue spheroids in desirable non-adhesive and lubricating hydrogel.
The second aspect of tissue spheroid functionalization is providing them with additional properties suitable for their translocation. For example, tissue spheroid could be either encapsulated into hydrogel containing magnetic nanoparticles or it could be encage in microscaffold also loaded with magnetic nanoparticles. In both case functionalization of tissue spheroid enables their magnetic levitation.
We recently developed a design concept of encaging tissue spheroids into interlockable microscaffold or functionality -they enable rapid bottom up bioassembly of cartilage or bone tissue from tissue spheroids. Lockyballs enable tissue spheroid retention and maintain shape of 3D construct and tissue spheroid will later fuse and form tissue.
Finally, functionalization of tissue spheroid could be directly related with tissue assembly process during bioprinting. For example, tissue spheroids encapsulated in hydrogel loaded with thrombin will be very easy and practically instantly be sintered by spraying fibrinogen solution and formation of fibrin hydrogel which will work as glue.
Some misconceptions about tissue spheroids based organ printing technology.
There are three main misconceptions about tissue spheroids in context of their using as building blocks in organ printing technology. First misconception is about revolutional novelty of solid scaffold free approach in tissue engineering, second misconception is about practical feasibility of organ printing technology and associated still persistent believe that organ printing is either still in science fiction domain or in infancy state. Finally he is misconception about principal incompatibility between solid scaffold and solid scaffold free approach in tissue engineering. Using polymer and hydrogel for 3D printing or rapid prototyping of acellular synthetic scaffolds is not an organ printing. 3D printing of cells suspended in hydrogel with low cell density is also not an organ printing. Organ printing is layer by layer deposition of tissue spheroid which can fused and which have maximal possible initial cell density. Now let consider issue of feasibility. Could situation when there are already at least five commercial companies in different countries around the world producing tissue spheroids and there are already five companies producing robotic bioprinters be defined such term as science fiction doma In really we are already facing dramatic translation from research to commercialization. Finally, is it possible to find compromise or common ground between traditional solid scaffold based tissue engineering approach and relatively new bottom-up modular microtissue based tissue engineering or it is completely incompatible research direction. Our concept of tissue spheroid encaged in interlockable solid microscaffold or question. The lockyball concept allows combining all biomimetic advantages of tissue spheroids approach with advantage of solid-scaffold based approach. However, it is important to underline that basic fundamental principle of bottom up approach is not compromised. Tissue spheroid encaged in solid interlockable microscaffold and encapsulated in think layer of lubricating hydrogel could be used for bioprinting.
It is also very important to indicate that tissue spheroid could have complex internal structure and composition and be pre-vascularized and prebuild in with high level of histological authenticity [22] . Finally, tissue spheroid could be printed together with solid or hydrogel scaffold and thus be incorporated into 3D solid scaffold of bioprinted cell-free hydrogel woodpile [23] .
Conclusion
Thus, presented data strongly indicate that scalable robotic biofabrication of tissue spheroids are not only technologically feasible but are already a subject of ongoing commercialization. It is a direct manifestation and reflection of general trend in biomedical robotizations and automation as the way to improve productivity and control the cost in biomedical industry. From another side, there are specific requirements for emerging bioprinting technology such as standardization of tissue spheroids size and shape, processibility, storage and large volumes which must be carefully addressed during development of new and optimization the existing scalable robotic biofabrication technology.
